AU2003252164A1 - Insulin-producing cell compositions and related methods - Google Patents

Insulin-producing cell compositions and related methods

Info

Publication number
AU2003252164A1
AU2003252164A1 AU2003252164A AU2003252164A AU2003252164A1 AU 2003252164 A1 AU2003252164 A1 AU 2003252164A1 AU 2003252164 A AU2003252164 A AU 2003252164A AU 2003252164 A AU2003252164 A AU 2003252164A AU 2003252164 A1 AU2003252164 A1 AU 2003252164A1
Authority
AU
Australia
Prior art keywords
insulin
related methods
producing cell
cell compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003252164A
Other versions
AU2003252164A8 (en
Inventor
Yuichi Hori
Seung Kim
Ingrid Rulifson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of AU2003252164A8 publication Critical patent/AU2003252164A8/en
Publication of AU2003252164A1 publication Critical patent/AU2003252164A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/22—Coculture with; Conditioned medium produced by pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/32—Polylysine, polyornithine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
AU2003252164A 2002-07-25 2003-07-25 Insulin-producing cell compositions and related methods Abandoned AU2003252164A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39893902P 2002-07-25 2002-07-25
US60/398,939 2002-07-25
US42663202P 2002-11-14 2002-11-14
US60/426,632 2002-11-14
PCT/US2003/023346 WO2004010933A2 (en) 2002-07-25 2003-07-25 Insulin-producing cell compositions and related methods

Publications (2)

Publication Number Publication Date
AU2003252164A8 AU2003252164A8 (en) 2004-02-16
AU2003252164A1 true AU2003252164A1 (en) 2004-02-16

Family

ID=31191239

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003252164A Abandoned AU2003252164A1 (en) 2002-07-25 2003-07-25 Insulin-producing cell compositions and related methods

Country Status (2)

Country Link
AU (1) AU2003252164A1 (en)
WO (1) WO2004010933A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2614728C2 (en) 2011-09-08 2017-03-28 Хексал Аг Pharmaceutical composition for oral administration containing statin
WO2016170069A1 (en) 2015-04-24 2016-10-27 University Of Copenhagen Isolation of bona fide pancreatic progenitor cells
CA2983845C (en) 2017-10-26 2024-01-30 University Of Copenhagen Generation of glucose-responsive beta cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165733A (en) * 1996-05-23 2000-12-26 Chiron Corporation γ II adaptin
US6242666B1 (en) * 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells

Also Published As

Publication number Publication date
WO2004010933A2 (en) 2004-02-05
AU2003252164A8 (en) 2004-02-16
WO2004010933A3 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
AU2003234666A1 (en) Methods and compositions for expanding and differentiating insulin-producing cells
AU2003220205A1 (en) Ethanol-diesel fuel composition and methods thereof
AU2003243531A1 (en) Fermentation methods and compositions
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
EP1578940A3 (en) Methods and compositions for diagnosing dysplasia
AU2003295511A1 (en) Methods and compositions for diagnosing dysplasia
AU2003270015A1 (en) Compounds, compositions, and methods
EP1518918A2 (en) Fuels compositions and methods for using same
AU2003247629A1 (en) Wet-developable anti-reflective compositions
AU2003299612A1 (en) Compounds, compositions and methods
AU2003256805A1 (en) Compounds compositions and methods
AU2003285288A1 (en) Composition
AU2003270636A1 (en) Foamable compositions
AU2003287443A1 (en) Compositions and methods for pain reduction
AU2003241313A1 (en) Compositions and methods for stem cell delivery
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU2002950744A0 (en) Composition
AU2003266815A1 (en) Immunoglobulin compositions and methods
AU2003235708A1 (en) Polytartrate composition
AU2003281687A1 (en) Photopolymerizable composition and use thereof
AU2003290507A1 (en) Compounds, compositions and methods
AU2003266282A1 (en) Compositions comprising muscle progenitor cells and uses thereof
AU2003277079A1 (en) Compounds, compositions, and methods